A separate study found that 72% of infants were protected against RSV through maternal vaccination or infant receipt of nirsevimab in 2023-24.
List of drugs that "when medically needed in acute care must be available and used within hours or days of the need or the patient may suffer serious outcomes which may include disability or death." Check the dashboards for the most recent shortages, or at the complete PDF list, updated every week.
Get Resilient Drug Supply updates in your inbox.
Supply chains were affected by both nationalism and international interdependence.
Cases continue to rise, led by the Western Pacific and Americas regions.
Experts say drug compounding is a stopgap measure, not a solution.
The agency prevented 199 drug shortages in 2020, its annual report says.
GAO's latest report looks at the VA's three main supply chain, COVID-related adaptations.
Though downstream disruptions affected naloxone access, upstream supply has been solid.
The review recommends investment in innovative manufacturing and greater FDA authority.
IQVIA's 5-year forecast estimates the pandemic's effects on the global pharmaceutical market.
Experts outline pre-COVID-19 problems and spell out key steps to take.
Researchers estimate Canada's potential demand for tocilizumab, a potential COVID-19 drug.
